16 | Dopamine (Intropin)FDA LinkGeneric
01/2022
-
01/2008 |
13 | Adenosine (Adenocard)FDA LinkGeneric
11/2020
-
01/2008 |
8 | Cholinergic Agents (Cholinergics)IBA
01/2016
-
01/2005 |
8 | Pharmaceutical PreparationsIBA
01/2016
-
01/2005 |
5 | Ethanol (Ethyl Alcohol)IBA
01/2021
-
12/2003 |
5 | Pimozide (Orap)FDA Link
11/2020
-
02/2005 |
5 | Pilocarpine (Ocusert)FDA LinkGeneric
01/2016
-
12/2004 |
4 | Caffeine (No Doz)FDA LinkGeneric
01/2021
-
01/2018 |
4 | Galantamine (Galanthamine)FDA LinkGeneric
01/2016
-
09/2011 |
3 | Monoamine Oxidase (MAO)IBA
01/2018
-
02/2016 |
3 | Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2016
-
09/2011 |
3 | Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
11/2013
-
10/2007 |
3 | CannabinoidsIBA
08/2013
-
07/2007 |
3 | Levodopa (L Dopa)FDA LinkGeneric
04/2013
-
10/2008 |
2 | Dopamine D2 Receptor AntagonistsIBA
11/2020
-
10/2010 |
2 | CytokinesIBA
10/2016
-
02/2014 |
2 | Tetrabenazine (Nitoman)FDA Link
02/2016
-
08/2015 |
2 | Muscarinic AgonistsIBA
01/2016
-
02/2010 |
2 | Serotonin (5 Hydroxytryptamine)IBA
08/2015
-
10/2008 |
2 | Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
08/2013
-
10/2010 |
2 | Dopamine Agonists (Dopamine Agonist)IBA
04/2013
-
01/2005 |
2 | gamma-Aminobutyric Acid (GABA)IBA
09/2012
-
12/2004 |
2 | Haloperidol (Haldol)FDA LinkGeneric
09/2012
-
03/2007 |
2 | CB1 Cannabinoid Receptor (CB1 Receptor)IBA
03/2008
-
07/2007 |
1 | CatecholaminesIBA
12/2021 |
1 | Bupropion (Wellbutrin)FDA LinkGeneric
12/2021 |
1 | Antidepressive Agents (Antidepressants)IBA
01/2021 |
1 | Theophylline (Theon)FDA LinkGeneric
11/2020 |
1 | Sucrose (Saccharose)IBA
01/2020 |
1 | SugarsIBA
01/2020 |
1 | SolutionsIBA
01/2020 |
1 | Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2018 |
1 | methylxanthineIBA
01/2018 |
1 | Interleukin-6 (Interleukin 6)IBA
10/2016 |
1 | Selegiline (E250)FDA LinkGeneric
02/2016 |
1 | Antiparkinson Agents (Antiparkinsonian Agents)IBA
01/2016 |
1 | Fluoxetine (Prozac)FDA LinkGeneric
08/2015 |
1 | Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA
08/2015 |
1 | MianserinIBA
08/2015 |
1 | 9- (hydroxymethyl)- 3- (1- adamantyl)hexahydrocannabinolIBA
08/2013 |
1 | safinamideIBA
04/2013 |
1 | Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
10/2012 |
1 | phosphoric acid mono- (2- (4- (3,3- dimethylbutyrylamino)- 3,5- difluorobenzoylimino)thiazol- 3- ylmethyl) esterIBA
01/2012 |
1 | Cholinergic Antagonists (Anticholinergics)IBA
01/2011 |
1 | 2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA
10/2010 |
1 | 1,3-dipropyl-8-cyclopentylxanthineIBA
02/2010 |
1 | 5- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA
02/2010 |
1 | Tacrine (Cognex)FDA Link
10/2008 |
1 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2008 |
1 | pimavanserinIBA
10/2008 |
1 | Urea (Carbamide)FDA LinkGeneric
10/2008 |
1 | 5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
10/2008 |
1 | SaltsIBA
10/2008 |
1 | PyrrolidinesIBA
10/2008 |
1 | istradefyllineIBA
05/2008 |
1 | AM4113IBA
03/2008 |
1 | Dopamine AntagonistsIBA
01/2008 |
1 | TropicamideFDA LinkGeneric
10/2007 |
1 | AtropineFDA LinkGeneric
10/2007 |
1 | Muscarinic AntagonistsIBA
10/2007 |
1 | Pergolide (Permax)FDA Link
01/2005 |
1 | ropinirole (Requip)FDA LinkGeneric
01/2005 |
1 | CY 208-243IBA
01/2005 |
1 | beta-AlanineIBA
12/2004 |
1 | GABA Uptake InhibitorsIBA
12/2004 |
1 | Acetates (Acetic Acid Esters)FDA Link
12/2003 |